NCT04513652View on ClinicalTrials.gov

A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 3, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

December 17, 2020

Conditions
Anesthesia, Local
Interventions
DRUG

AG-920

AG-920 Sterile Topical Ophthalmic Solution

DRUG

Placebo

Placebo Topical Ophthalmic Solution

Trial Locations (1)

92663

American Genomics Site 1, Newport Beach

Sponsors
All Listed Sponsors
lead

American Genomics, LLC

INDUSTRY